|1.||Hypertension (High Blood Pressure)
|1.||Elisaf, Moses S: 13 articles (02/2014 - 08/2003)|
|2.||Tada, Norio: 13 articles (10/2013 - 09/2002)|
|3.||Ridker, Paul M: 13 articles (04/2010 - 01/2002)|
|4.||Yamashita, Shizuya: 12 articles (09/2012 - 06/2003)|
|5.||Perova, N V: 12 articles (03/2007 - 03/2000)|
|6.||Wang, Hong: 11 articles (01/2016 - 11/2009)|
|7.||Lewis, Gary F: 11 articles (07/2015 - 06/2004)|
|8.||Li, Ying: 11 articles (02/2015 - 01/2009)|
|9.||Ferdinandy, Péter: 11 articles (02/2014 - 02/2002)|
|10.||Brocks, Dion R: 11 articles (02/2014 - 08/2002)|
06/01/2014 - "The multigrain diet used in the present study is effective in countering the hyperlipidemia and oxidative stress caused by high cholesterol intake."
08/01/2005 - "The LITA patency rate was significantly higher than that for SVG (p < 0.05) and the SVG patency rate was lower in the patients with hyperlipidemia (p < 0.05); cholesterol-lowering therapy improved the SVG patency rate. "
06/01/2004 - "The study demonstrated that pharmacists' individualized counseling, together with the assessment of cholesterol concentrations, had positive impacts on the management of hyperlipidemia, including improved drug compliance, better treatment endpoints, and patient satisfaction."
01/01/2012 - "Psillium certainly reduces levels of hyperlipidemia and could be recommended as hypolipidemic remedy for monotherapy as long as base datum of cholesterol is less than 6,4 mmol/l."
07/01/1999 - "Treatment of combined hyperlipidemia should be started with fibrate, but when the increment of cholesterol is superior to triglyceride, statin can be chosen. "
11/01/1998 - "The TG responses in plasma and TG-rich-lipoprotein (TRL) (d <1.006) after the oral fat load were significantly greater in NIDDMs with nephropathy compared to controls or NIDDMs without nephropathy, while such a marked postprandial lipemia was not observed in patients with primary renal disease. "
11/01/2000 - "We attempted to determine the effectiveness of exercise prescription for women with hyperlipidemia (HL), because some HL women showed no significant improvement in serum lipid and lipoprotein profiles despite the continuation of exercise conditioning. "
01/01/2013 - "Depending on study aims, for the use of the model it may be beneficial to perform single-dose assessments at time points later than 36 h when the lipoprotein concentrations will be more similar to those seen in patient with hyperlipidemia."
02/01/2006 - "A combination of preparative and analytical ultracentrifugation was used to investigate of LDL aliquots, to prepare radioactive-labeled lipoproteins and to study induced hyperlipidemia in rabbits. "
02/01/2006 - "The objective of this study was to investigate the lipoprotein profiles in Wistar rats and New Zealand white rabbits with experimentally induced hyperlipidemia by means of ultracentrifugation. "
|3.||atorvastatin (Lipitor)FDA Link
10/01/2000 - "These data confirm the marked efficacy and safety of atorvastatin in type 2 diabetic patients with hyperlipidemia and the efficacy of atorvastatin 10 mg in helping patients attain their LDL-C goal."
01/01/2007 - "Moreover atorvastatin improved although not completely normalized parameters of postprandial lipemia: significant lowering of baseline (-17%), 3 (-19%) and 6 hour (-14%) post load TG levels was noted. "
02/01/2015 - "Acupuncture combined with administration of Lipitor is effective in improving primary hyperlipidemia in patients, which is superior to administration of simple Lipitor."
05/01/2008 - "We examined the efficacy of atorvastatin as monotherapy in achieving a better or the same lipid profile in patients with mixed hyperlipidemia treated with combination therapy. "
08/01/2011 - "Both the generic and the reference atorvastatin were equally effective in correcting the lipid profile and reducing calculated absolute coronary risk in patients with hyperlipidemia and increased coronary risk. "
|4.||Glucose (Dextrose)FDA LinkGeneric
04/01/1990 - "These data suggest that glucose ingestion diminishes postprandial lipemia in a dose-dependent manner, but that this effect is not due to increased clearance of triglyceride from the circulation. "
04/30/1986 - "The optical aberrations due to the presence of the turbidity caused by hyperlipidemia has been eliminated in two serum glucose procedures. "
01/01/2015 - "To address this question of how glucose, when added to a fat load, affects the selected parameters of postprandial lipemia, we carried out a study in 30 healthy male volunteers. "
11/01/2012 - "Thirty-eight PCOS patients with hyperlipidemia and impaired glucose tolerance, who were followed at Department of Endocrinology and Metabolism out-patient clinic of Cerrahpasa Medical School were included in the study. "
04/01/2015 - "We estimated trends in CAD risk factors including age, sex, systolic blood pressure, diabetes (qualifying fasting glucose or medication), body mass index, smoking, and diagnosed hyperlipidemia. "
01/21/1989 - "A marked decrease (-36%) of plasma triglycerides was observed in 12 subjects with IIb hyperlipidemia. "
05/01/1992 - "Triglycerides above 275 mg per dL caused a significant reduction in measured activity of DAO; however, this effect could be eliminated by use of ultracentrifugation to remove lipemia. "
01/01/1986 - "The decreased clearance of circulating triglycerides appears to be the major mechanism contributing to hyperlipemia. "
01/01/1984 - "The decreased clearance of circulatory triglycerides appears to be the major mechanism contributing to hyperlipemia. "
06/01/2006 - "Postprandial lipemia and the incremental area under the triacylglycerol curve were not significantly different with the activity trials compared with the control trial. "
|6.||Insulin (Novolin)FDA Link
07/01/2013 - "Postprandial TAG and insulin responses to high-fat meals were elevated in these South Asian men, but acute exercise was equally, if not more, effective for reducing postprandial lipemia in South Asian than in European men."
11/01/2008 - "Additionally, the newer rapid-acting insulin analogues seem to be more effective in the reduction of postprandial lipemia than the short-acting human insulins. "
09/01/1992 - "Experiments in rat models of non-insulin-dependent diabetes demonstrated that TYL was markedly effective in treating hyperlipemia."
12/01/2008 - "She improved after optimized insulin therapy and intensified treatment of hyperlipidemia. "
11/01/1999 - "Fasting serum insulin, a crude, simple, practical, and inexpensive measure, independently and uniformly improved the prediction of ASCVD status beyond traditional risk factors and lipid variables in patients referred for treatment of hyperlipidemia."
|7.||Fenofibrate (CiL)FDA LinkGeneric
04/01/2006 - "The polymorphism of human IFABP gene in hyperlipidemia is related with the therapeutic efficacy of fenofibrate, and the T54T IFABP genotype may have strong negative effect on such efficacy."
01/01/1989 - "The first well-controlled studies of fenofibrate in the United States indicate that the drug is safe and effective for the treatment of type IIa and type IIb hyperlipidemia. "
01/03/1979 - "[Efficacy of procetofen (lipanthyl) in hyperlipidemias (author's transl)]."
03/01/2013 - "Lipid lowering studies in Triton induced hyperlipidemia rat model demonstrated higher lipid lowering ability for fenofibrate lipospheres compared to the commercial product and plain drug."
01/01/1989 - "Recent trials have investigated the usefulness of fenofibrate, alone and in combination with other lipid-lowering therapies, in the treatment of hyperlipidemia. "
|8.||Simvastatin (Zocor)FDA LinkGeneric
06/01/2009 - "In the short-term the combination of diet and simvastatin was effective in lowering hyperlipidemia in children with renal disorders."
03/01/2004 - "Simvastatin was an effective and generally well tolerated treatment for hyperlipidemia when used in combination with TZD therapy in this population of patients with type 2 DM."
03/01/2015 - "The study performed to evaluate the efficacy of Nigella sativa in comparison to simvastatin to treat hyperlipidemia. "
05/01/2008 - "This study suggests for the first time that simvastatin treatment in diabetic patients with hyperlipidemia is associated with an improvement in the heterogeneity of cardiac repolarization. "
03/01/2015 - "Simvastatin is a synthetic lipid lowering drug and Nigella sativa seeds found helpful in controlling hyperlipidemia. "
01/01/2008 - "In LN hyperlipidemia occurred more often (p = 0.055), lipids level and NS were not related during its remission. "
10/01/2007 - "The improving effect of (III) on serum lipids may be clinically effective for considering the pathologic condition of diabetes, which is often complicated by hyperlipidemia."
11/01/2011 - "To study the protective effects of Tianji soft capsule (TJSC) on blood lipids, internal antioxidant system and vascular endothelial system in hyperlipidemia rats. "
02/01/2004 - "[Observation of aerobic exercise effects improved on serum lipids in diet-induced hyperlipidemia mice]."
01/01/2001 - "In the liver, retarding of post prandial clearance of lipids contributes to hyperlipidemia. "
06/01/2011 - "In the hyperlipidemia cohort, low-density lipoprotein cholesterol control improved significantly between baseline and study end (22% to 34%, P = 0.0004). "
10/01/2010 - "Although fibrate monotherapy alone or in combination with non-statin low-density lipoprotein cholesterol-lowering agents can be effective in mixed hyperlipidemia when statins are not tolerated, the combination of statin+fibrate should be considered second-line therapy until the efficacy and safety are established."
02/01/2011 - "A total of 90 Japanese type 2 diabetes patients with hyperlipidemia (low-density lipoprotein cholesterol [LDL-C] ≥140 mg/dL) were enrolled in this study. "
06/01/2005 - "Recent findings have indicated that in an established rodent model of hyperlipidemia, moderate daily intakes of LPI-Es lead to a reduction of total and low-density lipoprotein cholesterol levels, and the knowledge of the actual composition of the protein sample used in that study is at the basis of further structure/action investigations. "
01/25/2001 - "Interventional studies confirmed the causative role of hyperlipidemia, particularly of the modified LDL-cholesterol. "
|1.||Blood Component Removal (Apheresis)
04/01/1996 - "The present data clearly demonstrate that treatment with LDL apheresis in patients suffering from severe familial hyperlipidemia, resistant to maximum conservative therapy, is very effective and safe even over long periods of time."
01/01/2012 - "The different published data clearly demonstrate that treatment with LDL-apheresis in patients suffering from severe hyperlipidemia refractory to maximum conservative therapy is effective and safe in long-term application."
08/01/2001 - "The published data clearly demonstrate that treatment with LDL-apheresis in patients suffering from severe hyperlipidemia refractory to maximum conservative therapy is effective and safe in long-term application."
02/01/2010 - "LDL-apheresis could be the first line treatment of isolated hyperLp(a)lipidemia when CAD is established. "
06/01/2011 - "This study aimed to investigate whether LDL apheresis was capable of reducing oxidative and atherogenic markers in uremic patients with hyperlipidemia. "
|2.||Transplantation (Transplant Recipients)
10/01/1996 - "GBP offers significant reduction in weight, HTN, PTDM and hyperlipidemia in morbidly obese kidney transplant recipients. "
06/01/2012 - "The results of this study suggest that late corticosteroid withdrawal is associated with better long-term graft survival without increasing the rates of diabetes, hyperlipidemia, or cardiovascular events in liver transplant recipients. "
09/01/2004 - "Forty-five renal transplant recipients with hyperlipidemia were enrolled in this study. "
06/01/2004 - "A long-term study on hyperlipidemia in stable renal transplant recipients."
09/01/1995 - "Emphasis was placed on clinical trials that investigated approaches to the treatment of hyperlipidemia in transplant recipients. "
12/15/2000 - "Posttransplantation hyperlipidemia can be treated in various ways, but statin therapy has thus far proved to be the most effective in lowering lipid levels in the transplant population. "
01/01/1996 - "Moreover, amelioration of hyperlipidemia may have improved transplant function. "
04/01/1995 - "Twelve renal transplant patients who had persistent hyperlipidemia despite 6 weeks of dietary treatment participated in this prospective, randomized, open-labeled crossover trial. "
01/01/1993 - "Isometric tension studies with ET-1 (10(-12) to 10(-6) M) showed that hyperlipidemia increased the maximal tension generated to ET-1 in the veins (660 +/- 80 to 1,110 +/- 140 mg, mean +/- SEM; p < 0.05), carotids (150 +/- 30 mg to 540 +/- 120 mg; p < 0.05), and vein grafts (180 +/- 20 to 450 +/- 60 mg; p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)"
09/01/2014 - "Evaluate the effect of experimental hyperlipidemia on the intensity of development of acute graft-versus-host reaction (GVHR) in mice. "
|4.||Drug Therapy (Chemotherapy)
05/01/2010 - "Besides drug therapy, a number of medicinal plants are effective in treating hyperlipidemia. "
05/15/1993 - "While diet is the mainstay of treatment for hyperlipidemia, drug therapy is necessary to achieve treatment goals in certain patients. "
08/15/2011 - "Intervention strategies (dietary and exercise advice, treatment switching, and pharmacotherapy) are required for persistent hyperlipidemia and should be assessed in randomized control trials."
11/01/2003 - "The aim of this study was to identify demographic, clinical, and pharmacotherapy-related factors associated with response to drug therapy for hyperlipidemia among members of a managed care organization. "
03/22/1999 - "Review of the hyperlipidemia drug therapy English-language medical literature with emphasis on randomized controlled trials of more than 6 weeks' duration published in the last 7 years, product package inserts, US Food and Drug Administration submission information, and NHANES III population statistics. "
02/01/1998 - "[Hyperlipidemia after kidney transplantation and its control by individualized therapy: evaluation of the first years' trial]."
01/01/1990 - "The purpose of our study was not to define the mechanisms of posttransplant hyperlipidemia, but rather to assess the effectiveness of dietary intervention on hyperlipidemia following renal transplantation."
09/01/1976 - "These studies suggest that the high rate of accelerated AS in dialysis patients is largely reversed by successful renal transplantation, probably due to a lowering of both blood pressure and hyperlipidemia in the long-term RT patients. "
01/01/2010 - "Hyperlipidemia is a common problem after kidney transplantation. "
01/01/2008 - "Hyperlipidemia following successful renal transplantation is a frequent and persistent complication. "